Citi Chops PT on Amarin (AMRN) to $13 on Lack of Vascepa Clarity, Financing Overhang
Tweet Send to a Friend
Amarin (Nasdaq: AMRN) is flat in early trading Monday, though one analyst sees a little more spending in the company's ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


